Strategic Account Executive (South)
Job Description
Key Skills Required
Master these to land this role
Want to know if you're a match for this job?
Freenome is seeking a Strategic Account Executive (South) to help redefine the landscape of early cancer detection by driving programmatic adoption of screening in health systems. The ideal candidate is proactive and driven and will be instrumental in adoption and implementation of Freenome’s early cancer detection tests and digital health platform. The Strategic Account Executive will meet sales goals within the assigned geography by networking and building relationships with health systems and institutions. You will partner with the implementation team to ensure adoption of Freenome’s tests. The successful candidate will be assessed on quality and quantity of contracts in accordance with Freenome’s high performing standards.
This role will be a Remote role within the South and will require the ability to travel 50% of working time away from work location, may include overnight/weekend travel.
What you’ll do:
- Become a subject matter expert in Freenome’s technology and service offerings, effectively representing the company to key stakeholders including C-suite, executives, KOL physicians, Medical Directors, Hospital Administrators, Lab Directors, Precision Medicine Directors and Senior Management of Partner Labs
- Be an amazing sales person, effectively articulating the value of Freenome’s industry leading tests and digital health tools to executive and provider leadership within health systems
- Partner with Medical Affairs to educate and recruit Health Systems to utilize Freenome’s test
- Negotiate and close contracts with health systems and institutions
- Collaborate with both internal and external stakeholders in order to implement EMR and UX tools that will drive growth of Freenome’s test
- Capture information on customer interactions using CRM tools, including point of contact information, sales call activities, market intelligence, funnel development, and other data points
- Provide feedback to the Product and Marketing team directly from customers
- Structure detailed strategic plans for gaining and retaining health systems and institution contracts
- Identify market opportunities, monitor competitive activity, and present findings to commercial leadership
Must haves:
- Bachelor’s Degree in Sales, Business Management, Marketing or, Science, or any other related field
- 10+ years of medical sales experience and 3+ years with a strong record of success selling complex diagnostics solutions to health systems or institutions
- Experience with institutional sales successfully closing and implementing contracts with health systems
- Understanding of the healthcare system, reimbursement pathways, and screening protocols
- Strong communication, negotiation, and stakeholder engagement skills
- Strong presentation skills: ability to effectively convey concepts in a clear, concise, and professional manner through telephone and face-to-face interactions
- Experience with CRM tools and data-driven account planning
- Ability to sell technically complex products
- Possession of a valid driver's license
Nice to haves:
- Experience with liquid biopsy early cancer detection
- Demonstrated experience promoting digital health solutions to health systems
- Experience selling disruptive technologies and improving the standard of care
How would you rate this job post?
See what other professionals think about this role.
Similar Opportunities
More Openings at Freenome
Explore Top Companies in this Space
Praxisprecisionmedicines
Biotechnology
Iovance Biotherapeutics
Biotechnology / Immuno-Oncology / Cell Therapy
Bioptimus8
Biotechnology
Mineralys Therapeutics
Biopharmaceuticals / Biotechnology / Healthcare / Cardiorenal Therapeutics
Freenome
View Company ProfileFreenome (operating under freenome.com) is a high-growth biotechnology and molecular diagnostics company that utilizes a proprietary AI-driven multiomics platform to pioneer non-invasive blood tests for early-stage cancer detection. Founded in 2014, the company shifts the paradigm of cancer screening away from isolated, single-analyte genomic testing. Instead, Freenome's platform integrates cell-free DNA (cfDNA), methylation patterns, genomic fragments, and programmatic protein biomarkers with advanced machine learning models to capture complex tumor signals and systemic immune responses at their earliest, most treatable stages. The company's foundational asset, the SimpleScreen colorectal cancer screening blood test, demonstrated exceptional clinical validation through its massive, prospective PREEMPT CRC clinical trial published in JAMA, meeting major efficacy endpoints for sensitivity and specificity. Capitalizing on this multiomic infrastructure, Freenome is aggressively scaling its diagnostic pipeline into a comprehensive Multi-Cancer Early Detection (MCED) portfolio targeting lung, pancreatic, and other high-mortality malignancies. Freenome has secured monumental, multi-million-dollar strategic commercialization and technology agreements with dominant industry pioneers, including a major global expansion partnership with Roche and an extensive distribution and licensing framework with Exact Sciences. Backed by over $1.4 billion in total funding from premier healthcare, tech, and life sciences institutional investors—including Andreessen Horowitz, Bain Capital Life Sciences, RA Capital, and Perceptive Advisors—Freenome entered into a definitive business combination agreement with Perceptive Capital Solutions Corp in late 2025 to transition into a publicly traded entity on the Nasdaq under the ticker FRNM. Headquartered in Brisbane, California, the organization operates sophisticated, CLIA-certified laboratory facilities and is led by industry veteran Dr. Aaron Elliott as Chief Executive Officer.
Safety First
- Never pay for a job application.
- Do not share sensitive bank info.
- Verify the client before starting work.